Oct 15, 2026 08:04AM
Oct 15, 2026 08:00AM
Oct 9, 2026 08:00AM
Sep 30, 2026 08:00AM
Sep 30, 2026 08:00AM
Sep 8, 2026 08:00AM
Aug 13, 2026 08:00AM Eupraxia reports swallowing symptom data from EoE drug trial
Aug 13, 2026 08:00AM
Aug 11, 2026 05:21PM
Jul 13, 2026 04:06PM
Jul 13, 2026 04:05PM
Jul 7, 2026 08:02AM
Jul 7, 2026 08:00AM
Jun 19, 2026 04:02PM Eupraxia Pharmaceuticals Announces Voting Results from Annual General Meeting of Shareholders
May 28, 2026 08:00AM
May 12, 2026 05:00PM
May 6, 2026 07:00AM
May 6, 2026 07:00AM
May 5, 2026 07:00AM
May 5, 2026 07:00AM
May 1, 2026 05:05PM Eupraxia Pharmaceuticals names Dr. Jeymi Tambiah as chief medical officer
May 1, 2026 05:05PM
Apr 22, 2026 07:00AM
Apr 21, 2026 07:00AM
Apr 21, 2026 07:00AM
Apr 13, 2026 08:00AM
Mar 17, 2026 07:00AM
Mar 17, 2026 07:00AM Eupraxia Pharmaceuticals Reports Six-Month Symptom Data from the Highest Dose Cohort in its Ongoing Phase 1b/2a RESOLVE Trial in Eosinophilic Esophagitis
Mar 12, 2026 09:03PM
Jan 8, 2026 07:34AM
Jan 8, 2026 07:34AM
Nov 13, 2025 05:00PM
Nov 13, 2025 05:00PM
Nov 4, 2025 04:39PM
Sep 29, 2025 05:00PM Eupraxia reports positive results from highest dose in EoE trial
Sep 29, 2025 05:00PM
Sep 2, 2025 08:02AM
Sep 2, 2025 08:00AM
Sep 2, 2025 08:00AM
Aug 12, 2025 04:25PM
Jul 22, 2025 05:17PM
Jul 8, 2025 07:00AM Eupraxia Doses First Patient in Phase 2b Placebo-Controlled Portion of EP-104GI RESOLVE Trial in Eosinophilic Esophagitis
Jul 8, 2025 07:00AM
Jun 2, 2025 06:30PM
May 7, 2025 02:00PM
May 6, 2025 06:00PM
May 5, 2025 07:00AM
Apr 24, 2025 05:00PM
Mar 20, 2025 05:32PM Eupraxia Pharmaceuticals Reports Fourth Quarter 2024 Financial Results
Feb 25, 2025 07:01AM

334,273 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All